774 related articles for article (PubMed ID: 34497171)
1. Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study.
Lin JL; Chen PS; Lin HW; Tsai LM; Lin SH; Li YH
J Atheroscler Thromb; 2022 Aug; 29(8):1213-1225. PubMed ID: 34497171
[TBL] [Abstract][Full Text] [Related]
2. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases.
Seo WW; Seo SI; Kim Y; Yoo JJ; Shin WG; Kim J; You SC; Park RW; Park YM; Kim KJ; Rhee SY; Park M; Jin ES; Kim SE
Cardiovasc Diabetol; 2022 May; 21(1):82. PubMed ID: 35606846
[TBL] [Abstract][Full Text] [Related]
3. Effect of Pitavastatin Compared with Atorvastatin andRosuvastatin on New-Onset Diabetes Mellitus in PatientsWith Acute Myocardial Infarction.
Choi JY; Choi CU; Hwang SY; Choi BG; Jang WY; Kim DY; Kim W; Park EJ; Lee S; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Chae SC; Kim YJ; Cho MC; Kim CJ; Kim HS; Jeong MH;
Am J Cardiol; 2018 Sep; 122(6):922-928. PubMed ID: 30217375
[TBL] [Abstract][Full Text] [Related]
4. Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.
Yoon D; Sheen SS; Lee S; Choi YJ; Park RW; Lim HS
Medicine (Baltimore); 2016 Nov; 95(46):e5429. PubMed ID: 27861386
[TBL] [Abstract][Full Text] [Related]
5. New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins.
Choi JY; Choi CU; Choi BG; Park Y; Kang DO; Jang WY; Kim W; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Jeong MH; Chae SC; Seong IW; Yoon CH; Cha KS; Oh SK;
BMC Pharmacol Toxicol; 2021 Feb; 22(1):11. PubMed ID: 33541430
[TBL] [Abstract][Full Text] [Related]
6. Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study.
Liu WT; Lin C; Tsai MC; Cheng CC; Chen SJ; Liou JT; Lin WS; Cheng SM; Lin CS; Tsao TP
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33202854
[TBL] [Abstract][Full Text] [Related]
7. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
[TBL] [Abstract][Full Text] [Related]
8. Risk of incident diabetes among patients treated with statins: population based study.
Carter AA; Gomes T; Camacho X; Juurlink DN; Shah BR; Mamdani MM
BMJ; 2013 May; 346():f2610. PubMed ID: 23704171
[TBL] [Abstract][Full Text] [Related]
9. Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial.
Park JB; Jung JH; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Sohn DW
Trials; 2017 Oct; 18(1):501. PubMed ID: 29078817
[TBL] [Abstract][Full Text] [Related]
10. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
[TBL] [Abstract][Full Text] [Related]
11. Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial.
Saku K; Zhang B; Noda K;
Circ J; 2011; 75(6):1493-505. PubMed ID: 21498906
[TBL] [Abstract][Full Text] [Related]
12. Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database.
Lee J; Noh Y; Shin S; Lim HS; Park RW; Bae SK; Oh E; Kim GJ; Kim JH; Lee S
Ther Clin Risk Manag; 2016; 12():1533-1543. PubMed ID: 27785041
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study.
Yu JM; Chen WM; Shia BC; Wu SY
Eur J Clin Pharmacol; 2023 May; 79(5):687-700. PubMed ID: 37010535
[TBL] [Abstract][Full Text] [Related]
14. Safety of High-Intensity Statins in the Veteran Population: Atorvastatin 40 to 80 mg Compared With Rosuvastatin 20 to 40 mg.
Stein B; Ward T; Hale G; Lyver E
Ann Pharmacother; 2020 May; 54(5):405-413. PubMed ID: 31718234
[No Abstract] [Full Text] [Related]
15. Pitavastatin for lowering lipids.
Adams SP; Alaeiilkhchi N; Wright JM
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012735. PubMed ID: 32557581
[TBL] [Abstract][Full Text] [Related]
16. Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study.
Trias F; Pintó X; Corbella E; Suárez-Tembra M; Ruíz-García A; Díaz-Díaz JL; Sánchez-Ruíz-Granado E; Sarasa I; Martínez-Porqueras R; Rodríguez-Sánchez MA; Corbella X;
Med Clin (Barc); 2022 Jun; 158(11):531-539. PubMed ID: 34517987
[TBL] [Abstract][Full Text] [Related]
17. Pitavastatin and Atorvastatin double-blind randomized comPArative study among hiGh-risk patients, including thOse with Type 2 diabetes mellitus, in Taiwan (PAPAGO-T Study).
Liu PY; Lin LY; Lin HJ; Hsia CH; Hung YR; Yeh HI; Wu TC; Chen JY; Chien KL; Chen JW
PLoS One; 2013; 8(10):e76298. PubMed ID: 24098467
[TBL] [Abstract][Full Text] [Related]
18. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of statin on new-onset diabetes in different age groups: a population-based case-control study in women from an asian country.
Chen CW; Chen TC; Huang KY; Chou P; Chen PF; Lee CC
PLoS One; 2013; 8(8):e71817. PubMed ID: 23951249
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over.
Kwak A; Kim JH; Choi CU; Kim IW; Oh JM; Kim K
Int J Clin Pharm; 2019 Apr; 41(2):460-469. PubMed ID: 30864086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
